Molecular Partners Ag (MOLN) Enterprise Value (2021 - 2026)

Molecular Partners Ag (MOLN) has reported Enterprise Value for 6 consecutive years, with $70.3 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 342.14% year-over-year to $70.3 million in Q2 2026; TTM through Jun 2026 was $70.3 million, a 342.14% increase from a year earlier, with the FY2025 full-year figure at $63.8 million, up 192.76% from the prior year.
• Enterprise Value was $70.3 million for Q2 2026 at Molecular Partners Ag, up from $59.7 million in the prior quarter.
• Over five years, Enterprise Value peaked at $342.8 million in Q1 2022 and troughed at -$84.7 million in Q3 2023.
• A 5-year average of $26.7 million and a median of $17.5 million in 2025 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value plunged 160.74% in 2023 and jumped 580.03% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at -$22.5 million in 2022, then sank by 160.74% to -$58.7 million in 2023, then soared by 135.85% to $21.1 million in 2024, then jumped by 182.87% to $59.6 million in 2025, then climbed by 18.03% to $70.3 million in 2026.
• The last three Enterprise Value figures came in at $70.3 million (Q2 2026), $59.7 million (Q1 2026), and $59.6 million (Q4 2025), per Business Quant data.